ArticleCancer reports (Hoboken, N.J.)2026

Salvage Therapy With Inotuzumab Ozogamicin in Relapsed/Refractory B-ALL After CAR-T Therapy and HSCT: A Case Series.

Honghu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.